EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Chemical Profiling and Quality Assessment of Renshen Zaizao Wan by HS‐GC‐IMS Combined With Chemometrics

Wu Bi, Xiaoyan Huang, Kehan Pei, Zhiyan Tan, Hui Sun iD, Ye Ding, Wenli Li

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Wu Bi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Institute for Drug Control, Changsha, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Gas Chromatography-Mass Spectrometry, Chemometrics, Ion Mobility Spectrometry. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renshen Zaizao Wan (RSZZW), a traditional Chinese patent drug originated in Qing dynasty, has been used clinically in China to treat stroke. It consists of 65 different types of plant‐, animal‐, and mineral‐derived Chinese medicinal herbs. However, current quality control of RSZZW mainly relies on a thin‐layer chromatography (TLC) method. It is difficult to perform quality assessment for this complicated Chinese patent drug. Therefore, the goal of this study is to simplify the identification process and provide a more comprehensive quality assessment method for RSZZW by developing an integrated strategy based on headspace–gas chromatography–ion mobility spectrometry (HS–GC–IMS) and multivariate statistical analysis. Forty‐six batches of commercial RSZZW from six different manufacturers were qualitatively analyzed. A total of 129 volatile signals were detected, of which 85 volatile organic compounds were identified, including 19 esters, 15 ketones, 11 terpenes, 11 alcohols, six aldehydes, and several others. By assessment of the ion mobility global profile, the samples from different manufacturers can be well distinguished by principal component analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalGas Chromatography-Mass SpectrometryChemometricsIon Mobility SpectrometryQuality ControlVolatile Organic CompoundsPrincipal Component AnalysisReproducibility of Results

Stichwörter der Autor:innen

Chinese patent drugHS‐GC‐IMSRenshen Zaizao Wanfingerprintquality assessment

Substanzen

Drugs, Chinese HerbalVolatile Organic Compounds

Autor:innen und Institutionen

  • Hunan Institute for Drug Control, Changsha, China.
  • Zhuzhou Qianjin Pharmaceutical Co., Ltd., Zhuzhou, China.
  • Chenzhou Center for Food and Drug Control, Chenzhou, China.

ORCID-Profile: Hui Sun

Förderung

  • Hunan Provincial Natural Science Foundation of China

Zitieren

APA

Bi, W., Huang, X., Pei, K., Tan, Z., Sun, H., Ding, Y., & Li, W. (2026). Comprehensive Chemical Profiling and Quality Assessment of Renshen Zaizao Wan by HS‐GC‐IMS Combined With Chemometrics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70271

Vancouver

Bi W, Huang X, Pei K, Tan Z, Sun H, Ding Y, et al. Comprehensive Chemical Profiling and Quality Assessment of Renshen Zaizao Wan by HS‐GC‐IMS Combined With Chemometrics. Biomedical Chromatography. 2026. doi:10.1002/bmc.70271

BibTeX
@article{Bi2026,
  author = {Bi, Wu and Huang, Xiaoyan and Pei, Kehan and Tan, Zhiyan and Sun, Hui and Ding, Ye and Li, Wenli},
  title = {Comprehensive Chemical Profiling and Quality Assessment of Renshen Zaizao Wan by HS‐GC‐IMS Combined With Chemometrics},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70271}
}
Kostenlos starten →